Aciphex and Ipf - a phase IV clinical study of FDA data

Summary:

Ipf is reported as a side effect among people who take Aciphex (rabeprazole sodium), especially for people who are female, 60+ old, also take Zometa, and have Metastases to bone.

The phase IV clinical study analyzes which people have Ipf when taking Aciphex. It is created by eHealthMe based on reports of 24,594 people who have side effects when taking Aciphex from the FDA, and is updated regularly.

What is Aciphex?

Aciphex has active ingredients of rabeprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 25,301 Aciphex users. Check the latest studies of Aciphex.

What is Ipf?

Ipf is found to be associated with 1,805 drugs and 2,276 conditions by eHealthMe. Check the latest studies of Ipf.

On May, 02, 2026

24,594 people reported to have side effects when taking Aciphex.
Among them, 55 people (0.22%) have Ipf.

Among these 55 people:

What is the gender of people who have Ipf when taking Aciphex? *

female: 62.26 %
male: 37.74 %

What is the age of people who have Ipf when taking Aciphex? *

What are other drugs people take besides Aciphex? *

What are other side effects people have besides Ipf? *

Pain: 30 people, 54.55%
Diarrhea: 29 people, 52.73%
Stress And Anxiety: 29 people, 52.73%
Abdominal Pain: 28 people, 50.91%
Insomnia (sleeplessness): 28 people, 50.91%
Swallowing Difficulty: 28 people, 50.91%
Nausea (feeling of having an urge to vomit): 27 people, 49.09%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 26 people, 47.27%
Nausea And Vomiting: 26 people, 47.27%
Sinus Tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node): 26 people, 47.27%

What are the existing conditions these people have? *

Metastases To Bone (cancer spreads to bone): 14 people, 25.45%
Bipolar I Disorder (mood disorder that is characterized by at least one manic or mixed episode): 13 people, 23.64%
Neoplasm Malignant (cancer tumour): 10 people, 18.18%
Breast Cancer: 10 people, 18.18%
Osteoporosis (bones weak and more likely to break): 4 people, 7.27%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 4 people, 7.27%
Barrett's Oesophagus (barrett's oesophagus is a disorder in which the lining of the oesophagus (the tube that carries food from the throat to the stomach) is damaged by stomach acid and changed to a lining similar to that of the stomach): 3 people, 5.45%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 3 people, 5.45%
Hepatitis C: 3 people, 5.45%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 3.64%

* Approximation only. Some reports may have incomplete information.

Do you take Aciphex and have Ipf?

- Check whether Ipf is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Aciphex:

Aciphex (25,301 reports)

Ipf treatments and more:

Ipf (79,193 reports)

Browse all side effects of Aciphex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ipf:

Ipf (1,805 drugs)

Browse all the conditions that are associated with Ipf:

Ipf (2,276 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on rabeprazole sodium (the active ingredients of Aciphex) and Aciphex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.